BioNTech SE (B1NT34) Share Price

Oh noooooo.....

OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I

Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.

Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum

The reversal on Friday just reflects the entire market downturn on Friday.

That sounds pretty optimistic to me. I'd think that the RA would like to see some data on other cancers before such a broad scope label.

I think he edited the question he asked to make it look neutral.

So the extra 5 to 6 million shares will help you pay the taxes on you gain?  That makes sense.

Dr. Jamil should know that once it is established that the primary endpoint has not been reached, it is widely recognised that it is not valid statistically to declare secondary endpoints and other sub-analyses as having reached statistical significance.

It’s a (not very) sophisticat

The Overhead Trendline, The 2.50 Level, The Overall Crypto Sector......

Boy.......what ppl steer clear of considering here is a real mindblower.......


https://investorshub.advfn.com/uimage/uploads/2025/1/13/rmobiXRP_!_12_45d_6pm_GLITCH_OHTL_250_SUMMARY.jpg

You contradict yourself......" style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"IF YOU owned P's, K's, or uq's ? ... the DTC Knows It' ... and, the DTC Knows EXACTLY How Many P's, K's, or uq's ... YO

Hello, I'm a newbie at AIM. Wondering if someone could recommend or provide a good spreadsheet?
roncderu@gmail.com.

If the predictions are correct it is going to be an interesting week.

PORTHOS still on schedule. Seems like spring/summer commissioning
https://www.linkedin.com/posts/porthos-co2_porthos-porthosco-co2-activity-7282763014376677376-qnb-?utm_source=share&utm_medium=member_android

https://www.linkedin.com/posts/activity-7275803191202447360-EX6x?utm

Hi all, thanks for happy new year wishes and I wish the same for all here too!

>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall

>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall

Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.

If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b

In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b

We will persevere!

>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari

We know who you are!

>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari